Pfizer Limited

PFIZER.NS

PFIZER.NSPfizer Limited IN flag

National Stock Exchange of India

5,517.00

INR

+43.00

(+0.79%)

167.91EPS

32.86P/E

252.39BMarket Cap

Jul 28Next Earn

Upgrade to Unlock Non-US CompaniesTo view real-time data and analysis of companies outside of the United States, upgrade your account to our premium subscription.

Upgrade

ISIN

INE182A01018

CUSIP

Y6890M120

Return %

Stock

S&P500

11.43

12.07

33.29

62.30

33.69

98.08

Use logarithmic scale

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	TTM
Revenue per Share	317.67	219.52	399.53	439.84	429.76	430.26	454.95	470.27	489.27	570.7	529.46	479.38	- -	498.63
Basic EPS, GAAP	168.62	48.28	15.26	66.66	73.61	78.7	93.78	111.28	108.77	133.89	136.38	120.51	- -	167.77
Free Cash Flow per Basic Share	-5.59	28.03	20.31	65.97	66.34	50.08	20.4	66.95	89.54	142.46	63.54	52	- -	- -
Dividend per Share	6.92	253.81	0.3	10.98	15	20.05	19.9	22.5	332.1	34.92	64.96	40.09	- -	- -
Book Value per Share	466.4	72.95	64.43	116.04	171.6	226.24	295.91	380.07	158.86	257.75	329.13	409.65	- -	10
Tangible Book Value per Share	567.81	143.92	230.01	292.23	354.89	403.95	487.19	583.19	376.1	490.12	576.08	663.13	- -	801.19
Basic Weighted Avg Shares	30	46	46	46	46	46	46	46	46	46	46	46	- -	46
Sales/Revenue/Turnover	9,480	10,043	18,277	20,123	19,662	19,685	20,814	21,515	22,384	26,110	24,223	21,932	22,814	22,814
Operating Margin (%)	18.92	23.39	14.24	18.87	14.67	22.21	24.01	22.67	27.17	27.6	29.26	26.13	29.78	29.78
Depreciation Expense	80	80	1,311	579	629	662	714	1,032	1,094	1,150	1,055	623	608	608
Net Income, GAAP	5,032	2,209	698	3,050	3,368	3,601	4,290	5,091	4,976	6,126	6,239	5,513	7,676	7,676
Effective Tax Rate (%)	27.47	34.96	57.84	35.17	34.84	34.28	34.98	20.76	25.59	20.74	24.28	26.1	24.46	24.46
Profit Margin (%)	53.08	21.99	3.82	15.16	17.13	18.29	20.61	23.66	22.23	23.46	25.76	25.14	33.65	33.65
Working Capital	14,535	3,826	7,110	9,741	12,716	14,623	18,237	21,749	11,341	15,436	18,677	22,230	29,433	29,433
LT Debt	- -	- -	25	25	25	- -	- -	887	427	1,277	933	544	676	676
Total Equity	16,944	6,584	19,215	21,635	24,189	26,832	30,113	33,955	23,930	28,644	32,073	35,955	42,174	42,174
Return on Invested Capital (%)	8.79	13.14	8.37	11.73	7.98	10.96	11.13	11.66	14.92	20.07	16.15	11.61	12.27	12.27
Return on Capital (%)	41.19	25.63	22.23	73.51	50.99	39.43	35.92	32.13	37.7	56.99	42.46	31.18	72.92	72.92
Return on Common Equity (%)	41.17	25.6	22.22	73.88	51.18	39.57	35.92	32.93	40.36	64.28	46.47	32.62	79.96	79.96

Capital Structure

•

in mil. unless spec.

Working Capital

•

in mil. unless spec.

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)	10 years	5 years	1 year
Sales/Revenue/Turnover	2.5%	1.6%	4.02%
Net Income, GAAP	44.23%	10.06%	39.23%
Free Cash Flow	55.46%	36.95%	165.48%
Total Cash Common Dividend	494.92%	264.35%	-12.64%
Total Equity	9.19%	6.31%	17.3%

Growth Rates

•

in mil. unless spec.

Quarterly Revenue

•

in mil. unless spec.

Quarterly Earnings Per Share

•

in mil. unless spec.

Quarterly Dividends Per Share

•

in mil. unless spec.

Company Description

CEO: Meenakshi Nevatia
Full Time Employees: 1,721
Sector: Healthcare
Industry: Drug Manufacturers - General
Address: The Capital Mumbai India 400051
IPO Date: Jul 1, 2002
Website: pfizerltd.co.in
Similar Companies: Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS)
Grifols, S.A. (GIFOF)
Marksans Pharma Limited (MARKSANS.NS)
Otsuka Holdings Co., Ltd. (OTSKY)
Biogen Inc. (BIIB)
PT Kalbe Farma Tbk. (PTKFF)
Business: Pfizer Limited manufactures, markets, trades in, and exports pharmaceutical products in India and internationally. The company offers its products in various therapeutic areas, including neuro/central nervous system, hormones, cardiovascular, hemophilia, anti-infectives, gynecology, pain/analgesics, orthopedic, oncology, urology, anti-parasitic, gastro intestinal, vaccines, respiratory, and vitamins/minerals/nutrients. It sells its products through a network of independent distributors primarily under various brand names. The company was incorporated in 1950 and is headquartered in Mumbai, India.

	Sep'25	Dec'25	Mar'25
ST Debt	369	- -	408
LT Borrowings	- -	- -	- -
LT Finance Leases	378	- -	676
Preferred Equity and Hybrid Capital	- -	- -	- -
Shares Outstanding	46	- -	46
Market Capitalization	261,767	241,640	183,215

	Sep'25	Dec'25	Mar'25
Total Current Assets	30,545	- -	35,128
Accounts Receivable, Net	2,275	- -	1,931
Cash, Cash Equivalents & STI	23,038	- -	28,049
Inventories	4,548	- -	4,759
Total Current Liabilities	6,047	- -	5,695
Payables & Accruals	- -	- -	- -
ST Debt	369	- -	408
Deferred Revenue	- -	- -	- -

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	TTM
Revenue per Share	317.67	219.52	399.53	439.84	429.76	430.26	454.95	470.27	489.27	570.7	529.46	479.38	- -	498.63
Basic EPS, GAAP	168.62	48.28	15.26	66.66	73.61	78.7	93.78	111.28	108.77	133.89	136.38	120.51	- -	167.77
Free Cash Flow per Basic Share	-5.59	28.03	20.31	65.97	66.34	50.08	20.4	66.95	89.54	142.46	63.54	52	- -	- -
Dividend per Share	6.92	253.81	0.3	10.98	15	20.05	19.9	22.5	332.1	34.92	64.96	40.09	- -	- -
Book Value per Share	466.4	72.95	64.43	116.04	171.6	226.24	295.91	380.07	158.86	257.75	329.13	409.65	- -	10
Tangible Book Value per Share	567.81	143.92	230.01	292.23	354.89	403.95	487.19	583.19	376.1	490.12	576.08	663.13	- -	801.19
Basic Weighted Avg Shares	30	46	46	46	46	46	46	46	46	46	46	46	- -	46
Sales/Revenue/Turnover	9,480	10,043	18,277	20,123	19,662	19,685	20,814	21,515	22,384	26,110	24,223	21,932	22,814	22,814
Operating Margin (%)	18.92	23.39	14.24	18.87	14.67	22.21	24.01	22.67	27.17	27.6	29.26	26.13	29.78	29.78
Depreciation Expense	80	80	1,311	579	629	662	714	1,032	1,094	1,150	1,055	623	608	608
Net Income, GAAP	5,032	2,209	698	3,050	3,368	3,601	4,290	5,091	4,976	6,126	6,239	5,513	7,676	7,676
Effective Tax Rate (%)	27.47	34.96	57.84	35.17	34.84	34.28	34.98	20.76	25.59	20.74	24.28	26.1	24.46	24.46
Profit Margin (%)	53.08	21.99	3.82	15.16	17.13	18.29	20.61	23.66	22.23	23.46	25.76	25.14	33.65	33.65
Working Capital	14,535	3,826	7,110	9,741	12,716	14,623	18,237	21,749	11,341	15,436	18,677	22,230	29,433	29,433
LT Debt	- -	- -	25	25	25	- -	- -	887	427	1,277	933	544	676	676
Total Equity	16,944	6,584	19,215	21,635	24,189	26,832	30,113	33,955	23,930	28,644	32,073	35,955	42,174	42,174
Return on Invested Capital (%)	8.79	13.14	8.37	11.73	7.98	10.96	11.13	11.66	14.92	20.07	16.15	11.61	12.27	12.27
Return on Capital (%)	41.19	25.63	22.23	73.51	50.99	39.43	35.92	32.13	37.7	56.99	42.46	31.18	72.92	72.92
Return on Common Equity (%)	41.17	25.6	22.22	73.88	51.18	39.57	35.92	32.93	40.36	64.28	46.47	32.62	79.96	79.96

Year	Q1	Q2	Q3	Q4	FY
2023	7.11	67.99	32.93	- -	136.38
2024	20.44	32.56	28.42	- -	120.51
2025	32.94	34.61	27.89	- -	- -

Year	Q1	Q2	Q3	Q4	FY
2023	5,929	6,375	6,218	5,726	24,223
2024	5,314	5,752	5,400	5,462	21,932
2025	5,629	5,886	5,380	5,919	22,814

Pfizer Limited

Growth Rates

(avg. rate of change)

Company Description

Growth Rates

(avg. rate of change)

Capital Structure

Working Capital

Quarterly Dividends Per Share

Year

Quarterly Earnings Per Share

Year

Quarterly Revenue

Year